V. Compan et al., OPPOSITE CHANGES IN STRIATAL NEUROPEPTIDE-Y IMMUNOREACTIVITY AFTER PARTIAL AND COMPLETE SEROTONERGIC DEPLETION IN THE RAT, Synapse, 24(1), 1996, pp. 87-96
The aim of this study was to investigate the consequences of partial v
s. complete serotonergic (5-HT) depletions on the immunoreactivity of
striatal interneurons containing neuropeptide Y (NPY). Taking into acc
ount the plasticity of the monoaminergic neurons, the effects of vario
us doses of 5,7-dihydroxytryptamine (5,7-DHT) injected into the anteri
or raphe nuclei and P-chlorophenylalanine (PCPA) administration were c
ompared in the dorsal (caudate-putamen) and the ventral(nucleus accumb
ens) striatum. Twenty days after administering 5,7-DHT injections indu
cing a substantial but partial decrease in the striatal 5-HT concentra
tions (about 80%), we detected a significant decrease in the number of
NPY immunoreactive cells. In contrast, the PCPA inhibition of seroton
in synthesis in the neurons spared by the partial lesion or the near-c
omplete neurotoxic lesion induced an increase in the number of striata
l NPY neurons. These results suggest that complex adaptive mechanisms
are probably responsible for the changes in striatal NPY reactivity ob
served after a partial lesion and that these neurons can adapt accordi
ng to the extent of 5-HT depletion. Upon comparing the NPY responses i
n the dorsal and ventral components of the striatal complex, no main d
ifferences were observed; while in the caudate-putamen, the changes we
re primarily found to occur in the medial zone. This finding is discus
sed here with reference to the topographical effects of dopaminergic o
r glutamatergic deafferentation. Finally, these results suggest that a
complete interruption of the 5-HT transmission may lead to an increas
e in the intracellular NPY level, which may be associated with a decre
ase in the release of the peptide. It can therefore be postulated that
serotonergic neurons normally exert a positive influence on NPY stria
tal neurons. (C) 1996 Wiley-Liss, Inc.